Tecfidera and Paclitaxel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tecfidera (dimethyl fumarate) and Paclitaxel (paclitaxel). Common drug interactions include lymphopenia among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Tecfidera and Paclitaxel. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Tecfidera?

Tecfidera has active ingredients of dimethyl fumarate. It is often used in multiple sclerosis. eHealthMe is studying from 129,627 Tecfidera users. Check the latest studies of Tecfidera.

What is Paclitaxel?

Paclitaxel has active ingredients of paclitaxel. It is often used in breast cancer. eHealthMe is studying from 85,928 Paclitaxel users. Check the latest studies of Paclitaxel.



On Aug, 04, 2026

13 people who take Tecfidera and Paclitaxel together, and have interactions are studied.

Tecfidera and Paclitaxel drug interactions.

What are the common drug interactions of Tecfidera and Paclitaxel, by gender? *:

female:

  1. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  2. Dyspnoea (difficult or laboured respiration)
  3. Hypersensitivity
  4. Bladder cancer recurrent
  5. Burning sensation
  6. Decreased appetite
  7. Diarrhoea
  8. Erythema (redness of the skin)
  9. Flatulence (flatus expelled through the anus)
  10. Flushing (the warm, red condition of human skin)

male:

  1. Pneumonia

What are the common drug interactions of Tecfidera and Paclitaxel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  2. Squamous cell carcinoma of the cervix (cervix cancer of a kind of epithelial cell)
  3. Cervix carcinoma (cancer of cervix)

40-49:

  1. Flushing (the warm, red condition of human skin)
  2. Muscle twitching
  3. Pain of skin
  4. Rhinorrhoea (watery mucus discharge from the nose)
  5. Bladder cancer recurrent
  6. Burning sensation
  7. Decreased appetite
  8. Diarrhoea
  9. Erythema (redness of the skin)

50-59:

  1. Dizziness
  2. Drug hypersensitivity
  3. Dyspnoea (difficult or laboured respiration)
  4. Hypersensitivity

60+:

  1. Pneumonia

What are the existing conditions these people have? *

  1. Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 6 people, 46.15%
  2. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 6 people, 46.15%
  3. High Blood Pressure: 2 people, 15.38%
  4. Wheezing (a high-pitched whistling sound made while you breath): 1 person, 7.69%
  5. Bipolar Disorder (mood disorder): 1 person, 7.69%
  6. Breast Neoplasm (non cancerous tumour of breast): 1 person, 7.69%
  7. Cough: 1 person, 7.69%
  8. Dyspnea (difficult or laboured breathing): 1 person, 7.69%
  9. Fatigue (feeling of tiredness): 1 person, 7.69%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Tecfidera and Paclitaxel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tecfidera and Paclitaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tecfidera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Paclitaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tecfidera and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Paclitaxel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dimethyl fumarate and paclitaxel (the active ingredients of Tecfidera and Paclitaxel, respectively), and Tecfidera and Paclitaxel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: